COMMUNIQUÉS West-GlobeNewswire

Publication relative à une notification de transparence
13/03/2026
INFORMATION RÉGLEMENTÉE Publication relative à une notification de transparence Mont-Saint-Guibert (Belgique), le 13 mars 2026 , 22:30h CET / 17:30h ET – Conformément à l'article 14 de la loi du 2 mai 2007 relative à la [...]
KFSH Leads Globally in Paired Kidney Transplants Performed at a Single Center in 2025
13/03/2026
RIYADH, Saudi Arabia, March 13, 2026 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research Centre (KFSH) achieved a global milestone by recording the highest number of kidneys paired donation transplants [...]
Publication relating to transparency notification
13/03/2026
REGULATED INFORMATION Publication relating to transparency notification Mont-Saint-Guibert (Belgium), March 13, 2026 , 10:30 pm CET / 5:30 pm ET – In accordance with article 14 of the Law of May 2, 2007 on the [...]
Vanish DrySerum Nanofiber Acne Mask Claims Evaluated: 2026 Consumer Research Report Examining Barrier Repair Technology, Ingredient Research, and What Consumers Should Verify Before Buying
14/03/2026
Vanish Skincare's nanofiber dry-fiber delivery format, barrier repair ingredient research, and published guarantee conditions examined for consumers researching acne mask options in 2026. Boca Raton, FL, March 13, 2026 [...]
InflaRx Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
13/03/2026
JENA, Germany, March 13, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that it has [...]
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
13/03/2026
Lead investor confirmed his intention to maintain his current shareholdings. Company does not anticipate using more than 1% of our authorized shares, including placement through the ATM, over the next 12 months or until [...]
Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa
13/03/2026
Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a decade 1-3 HS often emerges around puberty, underscoring importance of early diagnosis and [...]
Ipsen - February 2026 - Monthly information relative to the total number of voting rights and shares composing the share capital
13/03/2026
Monthly information relative to the total number of voting rights and shares composing the share capital (in accordance with Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Regulation [...]
ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases
13/03/2026
Key Highlights Ongoing open-ended discretionary stock purchases by the president and chairman, demonstrating confidence in TXTM’s growth and future. No salaries paid from inception to date, ensuring financial discipline [...]
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
13/03/2026
WARREN, N.J., March 13, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ) today announced performance advancements for its artificial intelligence platform, operated through [...]
Disclosure of a transparency notification from Mawer Investment Management Ltd
13/03/2026
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 13 March 2026 – 6 PM CET Disclosure of a transparency notification from Mawer Investment Management Ltd Pursuant to the Belgian act of 2 May 2007 on [...]
Prospective, Multi-center Study Published in Future Oncology Demonstrates DecisionDx®-Melanoma’s i31-SLNB Result Outperforms Staging Criteria in Identifying Patients with Cutaneous Melanoma Below the 5% NCCN Threshold for Forgoing SLNB
13/03/2026
Among all patients studied, 2.6% nodal positivity and 97.8% three-year recurrence-free survival (RFS) was observed in those predicted to have less than 5% risk of a positive sentinel lymph node (SLN) by DecisionDx- [...]
How Scientists Measure the Circulation You Actually Feel — Not Just the Arteries They Can See
13/03/2026
The Human Vascular System Stretches Up to 100,000 Miles — Standard Imaging Captures Only a Fraction of It The Endothelial Glycocalyx: A Microscopic Lining That Helps Regulate How Blood Moves Through the Smallest Vessels [...]
Ipsen - Février 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
13/03/2026
Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social (conformément à l’article L.233-8 II du Code de commerce et à l’article 223-16 du Règlement Général de l’ [...]
Akari Therapeutics Releases CEO Corner Highlighting Strategic Progress and Path to Clinical Development Under CEO Abizer Gaslightwala
13/03/2026
Highlights strategic progress achieved under Abizer Gaslightwala’s leadership, including advancement of AKTX-101 and expansion of Akari’s ADC pipeline Access the Akari CEO Corner here TAMPA, Fla. and LONDON, March 13, [...]
Sienna Announces March Dividend
13/03/2026
MARKHAM, Ontario, March 13, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) today announced a dividend of $0.078 per common share of the Company (each, a “ Common Share ”) [...]
New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row
13/03/2026
Ranked Top 50 in the Nation for 2026 New York, NY, March 13, 2026 (GLOBE NEWSWIRE) -- New York Plastic Surgical Group (NYPS Group) and Deep Blue Med Spa (DBMS) are proud to announce that they have once again been [...]
Lifeward Receives Shareholder Approval to Close on Strategic Partnership with Oramed—Creating Diversified Biomedical Company
13/03/2026
Position s Lifeward as a diversified biomedical innovation company with clear path to profitability Integration of Oramed’s POD™ oral delivery technology expands Lifeward into biotech markets while Oramed funds the [...]
UroGen Applauds BCAN’s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence
13/03/2026
National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50 Many respondents report undergoing five or more cystoscopies, with some [...]

Pages